---
title: "Why Shattuck Labs stock soared in December"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/271602890.md"
description: "Buttressed by a significant amount of fresh capital, the company is showing progress in the early development of its top investigational drug."
datetime: "2026-01-06T04:42:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271602890.md)
  - [en](https://longbridge.com/en/news/271602890.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271602890.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/271602890.md) | [English](https://longbridge.com/en/news/271602890.md)


# Why Shattuck Labs stock soared in December

Buttressed by a significant amount of fresh capital, the company is showing progress in the early development of its top investigational drug.

### 相關股票

- [Shattuck Labs (STTK.US)](https://longbridge.com/zh-HK/quote/STTK.US.md)

## 相關資訊與研究

- [Why Shattuck Labs stock soared more than 53% higher this week](https://longbridge.com/zh-HK/news/278178348.md)
- [20:00 ETPRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement](https://longbridge.com/zh-HK/news/278957605.md)
- [Legend sloughs off Carvykti threat from J&J's Tecvayli](https://longbridge.com/zh-HK/news/278925660.md)
- [09:45 ETMedical Knowledge Group Appoints David Margines to Board of Directors, Advancing Its Legacy in AI- and Analytics-Driven Drug Commercialization](https://longbridge.com/zh-HK/news/278896967.md)
- [EXCLUSIVE: Healthcare Startup Andel Says Its Employer GLP-1 Model Bypasses PBMs, May Lower Costs For Eli Lilly's Zepbound](https://longbridge.com/zh-HK/news/278730224.md)